Document is current
Any future updates will be listed below
-
Authors
Strle, Franc https://orcid.org/0000-0003-4163-0503
Ogrinc, Katarina
Maraspin, Vera
Lotrič-Furlan, Stanka
Rojko, Tereza
Ružić-Sabljić, Eva
Kastrin, Andrej
Strle, Klemen
Wormser, Gary P.
Bogovič, Petra
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06835075 at ClinicalTrials.govDocuments that mention this clinical trial
Clinical data on symptomatic cutaneous reinfections due to Borrelia burgdorferi sensu lato in Slovenia
https://doi.org/10.1007/s15010-026-02751-9
-
Funding
Funding for this research was provided by:
Slovenian Research and Innovation Agency (P3-0296, J3-7086, and J3-8195)
University Medical Centre Ljubljana, Slovenia (20220144)
National Institutes of Health [National Institute of Allergy and Infectious Diseases] (R21AI144916 and R21AI14927802)
- License Information
-
More Information
Article History
Received: 15 December 2025
Accepted: 13 February 2026
First Online: 17 February 2026
Declarations
:
: K.S. served as a consultant for Roche, BioMerieux, and NYS Biodefense Fund, for the development of diagnostic assays in Lyme borreliosis. G.P.W. reports receiving a research grant from Biopeptides, Corp. He has been an expert witness in malpractice cases involving Lyme disease and babesiosis; and is an unpaid board member of the non-profit American Lyme Disease Foundation. He has been involved in two patents: U.S. Patent No. 10,669,567 B2 (Title: HIGH SENSITIVITY METHOD FOR EARLY LYME DISEASE DETECTION; Issue Date: June 2, 2020) andU.S. Patent No. 11230728 (Title: DIFFERENTIATION OF LYME DISEASE AND SOUTHERN TICK-ASSOCIATED RASH ILLNESS; Issue Date: 1/25/22). F.S. is editorial board member of Infection. He served on the scientific advisory board for Roche on Lyme disease serological diagnostics and on the scientific advisory board for Pfizer on Lyme disease vaccine, and is an unpaid member of the steering committee of the ESCMID Study Group on Lyme Borreliosis/ESGBOR. Other authors report there are no competing interests to declare.
